SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Hengstman GJ, van den Hoogen FH, van Engelen BG.Treatment of the inflammatory myopathies: update and practical recommendations.Expert Opin Pharmacother2009;10:118390.
  • 2
    Harris-Love MO, Shrader JA, Koziol D, Pahlajani N, Jain M, Smith M, et al.Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis.Rheumatology (Oxford)2009;48:1349.
  • 3
    Marie I, Hachulla E, Hatron PY, Hellot MF, Levesque H, Devulder B, et al.Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.J Rheumatol2001;28:22307.
  • 4
    Sultan SM, Ioannou Y, Moss K, Isenberg DA.Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality.Rheumatology (Oxford)2002;41:226.
  • 5
    Ponyi A, Borgulya G, Constantin T, Vancsa A, Gergely L, Danko K.Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis.Rheumatology (Oxford)2005;44:838.
  • 6
    Bronner IM, van der Meulen MF, de Visser M, Kalmijn S, van Venrooij WJ, Voskuyl AE, et al.Long-term outcome in polymyositis and dermatomyositis.Ann Rheum Dis2006;65:145661.
  • 7
    Regardt M, Welin Henriksson E, Alexanderson H, Lundberg IE.Patients with polymyositis or dermatomyositis have reduced grip force and health-related quality of life in comparison with reference values: an observational study.Rheumatology (Oxford)2011;50:57885.
  • 8
    Zong M, Lundberg IE.Pathogenesis, classification and treatment of inflammatory myopathies.Nat Rev Rheumatol2011;7:297306.
  • 9
    Lakka TA, Venalainen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT.Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction.N Engl J Med1994;330:154954.
  • 10
    Wiesinger GF, Quittan M, Nuhr M, Volc-Platzer B, Ebenbichler G, Zehetgruber M, et al.Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls.Arch Phys Med Rehabil2000;81:15.
  • 11
    Alexanderson H, Lundberg IE.Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies.Curr Opin Rheumatol2012;24:2017.
  • 12
    Habers GE, Takken T.Safety and efficacy of exercise training in patients with an idiopathic inflammatory myopathy: a systematic review.Rheumatology (Oxford)2011;50:211324.
  • 13
    Nader GA, Lundberg IE.Exercise as an anti-inflammatory intervention to combat inflammatory diseases of muscle.Curr Opin Rheumatol2009;21:599603.
  • 14
    Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA.The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease.Nat Rev Immunol2011;11:60715.
  • 15
    Alexanderson H, Dastmalchi M, Esbjornsson-Liljedahl M, Opava CH, Lundberg IE.Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis.Arthritis Rheum2007;57:76877.
  • 16
    Nader GA, Dastmalchi M, Alexanderson H, Grundtman C, Gernapudi R, Esbjornsson M, et al.A longitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis.Mol Med2010;16:45564.
  • 17
    Wiesinger GF, Quittan M, Aringer M, Seeber A, Volc-Platzer B, Smolen J, et al.Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme.Br J Rheumatol1998;37:196200.
  • 18
    Wiesinger GF, Quittan M, Graninger M, Seeber A, Ebenbichler G, Sturm B, et al.Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients.Br J Rheumatol1998;37:133842.
  • 19
    Bohan A, Peter JB.Polymyositis and dermatomyositis (first of two parts).N Engl J Med1975;292:3447.
  • 20
    Bohan A, Peter JB.Polymyositis and dermatomyositis (second of two parts).N Engl J Med1975;292:4037.
  • 21
    Sullivan M, Karlsson J, Ware JE Jr.The Swedish SF-36 health survey. I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden.Soc Sci Med1995;41:134958.
  • 22
    Alemo Munters L, van Vollenhoven RF, Alexanderson H.Patient preference assessment reveals disease aspects not covered by recommended outcomes in polymyositis and dermatomyositis.ISRN Rheumatol2011;2011:463124.
  • 23
    Verhoeven AC, Boers M, van der Liden S.Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial.J Rheumatol2000;27:28019.
  • 24
    Alexanderson H, Lundberg IE, Stenstrom CH.Development of the Myositis Activities Profile: validity and reliability of a self-administered questionnaire to assess activity limitations in patients with polymyositis/dermatomyositis.J Rheumatol2002;29:238692.
  • 25
    Borg GA.Perceived exertion.Exerc Sport Sci Rev1974;2:13153.
  • 26
    Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, et al.International consensus outcome measures for patients with idiopathic inflammatory myopathies: development and initial validation of myositis activity and damage indices in patients with adult onset disease.Rheumatology (Oxford)2004;43:4954.
  • 27
    Sultan SM, Allen E, Cooper RG, Agarwal S, Kiely P, Oddis CV, et al.Interrater reliability and aspects of validity of the myositis damage index.Ann Rheum Dis2011;70:12726.
  • 28
    Weiss RE.Modeling longitudinal data.New York:Springer;2005.
  • 29
    Munro B.Statistical methods for health care research. 3rd ed.Philadelphia:JB Lippincott;1997.
  • 30
    Paulus HE, Egger MJ, Ward JR, Williams HJ, and the Cooperative Systematic Studies of Rheumatic Diseases Group.Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo.Arthritis Rheum1990;33:47784.
  • 31
    Rider LG, Giannini EH, Brunner HI, Ruperto N, James-Newton L, Reed AM, et al, for the International Myositis Assessment and Clinical Studies Group.International Consensus on preliminary definitions of improvement in adult and juvenile myositis.Arthritis Rheum2004;50:228190.
  • 32
    Bjorner JB, Wallenstein GV, Martin MC, Lin P, Blaisdell-Gross B, Tak Piech C, et al.Interpreting score differences in the SF-36 vitality scale: using clinical conditions and functional outcomes to define the minimally important difference.Curr Med Res Opin2007;23:7319.
  • 33
    Alexanderson H, Stenstrom CH, Lundberg I.Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study.Rheumatology (Oxford)1999;38:60811.
  • 34
    Penedo FJ, Dahn JR.Exercise and well-being: a review of mental and physical health benefits associated with physical activity.Curr Opin Psychiatry2005;18:18993.
  • 35
    Neill J, Belan I, Ried K.Effectiveness of non-pharmacological interventions for fatigue in adults with multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus: a systematic review.J Adv Nurs2006;56:61735.
  • 36
    Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE.Exercise capacity and mortality among men referred for exercise testing.N Engl J Med2002;346:793801.
  • 37
    Sokka T, Hakkinen A.Poor physical fitness and performance as predictors of mortality in normal populations and patients with rheumatic and other diseases.Clin Exp Rheumatol2008;26 Suppl:S1420.
  • 38
    Warburton DE, Nicol CW, Bredin SS.Health benefits of physical activity: the evidence.CMAJ2006;174:8019.
  • 39
    Walsh NP, Gleeson M, Shephard RJ, Woods JA, Bishop NC, Fleshner M, et al.Position statement. Part one: immune function and exercise.Exerc Immunol Rev2011;17:663.
  • 40
    Sloan RP, Shapiro PA, Demeersman RE, McKinley PS, Tracey KJ, Slavov I, et al.Aerobic exercise attenuates inducible TNF production in humans.J Appl Physiol2007;103:100711.
  • 41
    Petersen AM, Pedersen BK.The anti-inflammatory effect of exercise.J Appl Physiol2005;98:115462.
  • 42
    Gielen S, Adams V, Mobius-Winkler S, Linke A, Erbs S, Yu J, et al.Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure.J Am Coll Cardiol2003;42:8618.
  • 43
    Greiwe JS, Cheng B, Rubin DC, Yarasheski KE, Semenkovich CF.Resistance exercise decreases skeletal muscle tumor necrosis factor α in frail elderly humans.FASEB J2001;15:47582.
  • 44
    Tracey KJ.Reflex control of immunity.Nat Rev Immunol2009;9:41828.
  • 45
    De Jong Z, Munneke M, Zwinderman AH, Kroon HM, Jansen A, Ronday KH, et al.Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial.Arthritis Rheum2003;48:241524.
  • 46
    Verhoeven AC, Boers M, van der Linden S.Responsiveness of the core set, response criteria, and utilities in early rheumatoid arthritis.Ann Rheum Dis2000;59:96674.
  • 47
    Nguyen C, Mouthon L, Mestre-Stanislas C, Rannou F, Berezne A, Sanchez K, et al.Sensitivity to change in systemic sclerosis of the McMaster-Toronto Arthritis Patient Preference Disability Questionnaire (MACTAR): shift in patient priorities over time.J Rheumatol2010;37:35964.
  • 48
    Bogdanis GC.Effects of physical activity and inactivity on muscle fatigue.Front Physiol2012;142:115.
  • 49
    Avery L, Flynn D, van Wersch A, Sniehotta FF, Trenell MI.Changing physical activity behavior in type 2 diabetes: a systematic review and meta-analysis of behavioral interventions.Diabetes Care2012;35:26819.
  • 50
    Boutron I, Moher D, Altman DG, Schultz KF, Ravaud P.Methods and processes of the CONSORT group: example of an extension of trials assessing nonpharmacologic treatments.Ann Intern Med2008;148:606.